167 related articles for article (PubMed ID: 6672466)
1. [Cardiovascular effects of urapidil].
Bousquet P; Decker N; Feldman J; Schwartz J
J Pharmacol; 1983; 14(4):465-72. PubMed ID: 6672466
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of the hypotensive action of urapidil.
Bousquet P; Feldman J; Schwartz J
J Hypertens Suppl; 1985 Dec; 3(3):S187-9. PubMed ID: 2856701
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects and interaction with adrenoceptors of urapidil.
van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
[TBL] [Abstract][Full Text] [Related]
4. Effects of urapidil on blood pressure and adrenoceptors in various animal models.
van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB
J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713
[TBL] [Abstract][Full Text] [Related]
5. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
Sanders KH; Beller KD; Bischler P; Kolassa N
J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of urapidil.
Prichard BN; Renondin JC; Tomlinson B
J Hypertens Suppl; 1988 Dec; 6(2):S13-9. PubMed ID: 2906695
[TBL] [Abstract][Full Text] [Related]
7. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
Shebuski RJ; Zimmerman BG
J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
[TBL] [Abstract][Full Text] [Related]
8. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
Goering J; Zimmerman BG
J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo.
Zech K; Eltze M; Kilian U; Sanders KH; Kolassa N
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):180-96. PubMed ID: 6098228
[TBL] [Abstract][Full Text] [Related]
10. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
Mandal AK; Kellar KJ; Friedman E; Pineo SV; Hamosh P; Gillis RA
J Pharmacol Exp Ther; 1989 Nov; 251(2):563-70. PubMed ID: 2530339
[TBL] [Abstract][Full Text] [Related]
11. [The central and peripheral components in the mechanism of action of urapidil].
Maĭorov DN; Medvedev OS
Eksp Klin Farmakol; 1992; 55(1):31-3. PubMed ID: 1305430
[TBL] [Abstract][Full Text] [Related]
12. Experimental studies on the neurocardiovascular effects of urapidil.
Gillis RA; Kellar KJ; Quest JA; Namath IJ; Martino-Barrows A; Hill K; Gatti PJ; Dretchen K
Drugs; 1988; 35 Suppl 6():20-33. PubMed ID: 2900129
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and circulatory response to the intravenous administration of urapidil during general anaesthesia.
Fontana F; Allaria B; Brunetti B; Arienta R; Favaro M; Trivellato A; Rusconi MG
Drugs Exp Clin Res; 1990; 16(6):315-8. PubMed ID: 2086167
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive effect of urapidil: CNS site and relative contribution.
Gillis RA; Dretchen KL; Namath I; Anastasi N; Dias Souza J; Hill K; Browne RK; Quest JA
J Cardiovasc Pharmacol; 1987 Jan; 9(1):103-9. PubMed ID: 2434784
[TBL] [Abstract][Full Text] [Related]
15. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
16. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
Chin W; Nakagawa Y; Mitomi A; Imai S
Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
[TBL] [Abstract][Full Text] [Related]
17. Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
Sanders KH; Jurna I
Eur J Pharmacol; 1985 Apr; 110(2):181-90. PubMed ID: 3987812
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and neural effects of urapidil and prazosin in essential hypertensives.
Grassi G; Seravalle G; Mancia G; Zanchetti A
Blood Press Suppl; 1994; 4():13-8. PubMed ID: 7804507
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic profile of urapidil.
van Zwieten PA
Am J Cardiol; 1989 Aug; 64(7):1D-6D. PubMed ID: 2569262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
